The Treatment of Malaria with Iron Chelators
- 1 April 1997
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 49 (Supplement) , 59-64
- https://doi.org/10.1111/j.2042-7158.1997.tb06162.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- The Relationship of Intracellular Iron Chelation to the Inhibition and Regeneration of Human Ribonucleotide ReductaseJournal of Biological Chemistry, 1996
- Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytesBiochemical Journal, 1995
- Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potentialJournal of Medicinal Chemistry, 1993
- Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from ThailandActa Tropica, 1992
- Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle.Proceedings of the National Academy of Sciences, 1990
- Altered membrane transport of malaria-infected erythrocytes: a possible pharmacologic targetBlood, 1989
- Plasmodium falciparum: Inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocinExperimental Parasitology, 1987
- Effect of iron-chelating agents on inhibitors of ribonucleotide reductaseBiochemical Pharmacology, 1981
- Effect of various iron chelating agents on DNA synthesis in human cellsBiochemical Pharmacology, 1980
- Why are some metal‐binding substances anti‐bacterial?Recueil des Travaux Chimiques des Pays-Bas, 1956